Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $11.83 | N/A |
Market Cap | $172.31M | N/A |
Shares Outstanding | 14.57M | N/A |
Employees | 973.00 | N/A |